These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 15893838

  • 21. Theiler's murine encephalomyelitis virus preferentially infects immature stages of the murine oligodendrocyte precursor cell line BO-1 and blocks oligodendrocytic differentiation in vitro.
    Pringproa K, Rohn K, Kummerfeld M, Wewetzer K, Baumgärtner W.
    Brain Res; 2010 Apr 23; 1327():24-37. PubMed ID: 20206147
    [Abstract] [Full Text] [Related]

  • 22. Expression and potential role of inducible nitric oxide synthase in the central nervous system of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Iwahashi T, Inoue A, Koh CS, Shin TK, Kim BS.
    Cell Immunol; 1999 Jun 15; 194(2):186-93. PubMed ID: 10383821
    [Abstract] [Full Text] [Related]

  • 23. A lentiviral expression system demonstrates that L* protein of Theiler's murine encephalomyelitis virus (TMEV) has an anti-apoptotic effect in a macrophage cell line.
    Himeda T, Ohara Y, Asakura K, Kontani Y, Sawada M.
    Microb Pathog; 2005 Jun 15; 38(5-6):201-7. PubMed ID: 15925271
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide.
    Mendez-Fernandez YV, Johnson AJ, Rodriguez M, Pease LR.
    Eur J Immunol; 2003 Sep 15; 33(9):2501-10. PubMed ID: 12938226
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Theiler's virus induces the MIP-2 chemokine (CXCL2) in astrocytes from genetically susceptible but not from resistant mouse strains.
    Rubio N, Sanz-Rodriguez F, Lipton HL.
    Cell Immunol; 2006 Jan 15; 239(1):31-40. PubMed ID: 16684516
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Chemokine expression in the central nervous system of mice with a viral disease resembling multiple sclerosis: roles of CD4+ and CD8+ T cells and viral persistence.
    Ransohoff RM, Wei T, Pavelko KD, Lee JC, Murray PD, Rodriguez M.
    J Virol; 2002 Mar 15; 76(5):2217-24. PubMed ID: 11836399
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Viral hyperinfection of the central nervous system and high mortality after hematopoietic stem cell transplantation for treatment of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Burt RK, Padilla J, Dal Canto MC, Miller SD.
    Blood; 1999 Oct 15; 94(8):2915-22. PubMed ID: 10515897
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Altered cell growth and morphology in a BHK-21 cell mutant that lacks a receptor for Theiler's murine encephalomyelitis virus.
    Libbey JE, Tsunoda I, Fujinami RS.
    Virology; 2002 Mar 01; 294(1):85-93. PubMed ID: 11886268
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.